1,354,700 research outputs found
PoliTo in Light. Progetto e realizzazione di un'installazione temporanea luminosa nella corte d'onore del Castello del Valentino a Torino
No full textL'articolo presenta gli esiti del progetto PoliTo in Light, attività ideata da un gruppo di studenti e resa concreta grazie al sostegno della Commissione Contributi e Progettualità studentesca del Politecnico di Torino. Sotto la referenza scientifica delle Prof.sse Chiara Aghemo, Annalisa Dameri e Costanza Roggero e la guida tecnica del Laboratorio di Anali e Modellazione dei sistemi ambientali (LAMSA - DAD), gli studenti si sono confrontati con il tema del lighting design e del suo rapporto con contesti di eccezionale valore culturale, come il caso del Castello del Valentino. Il progetto, nato con la collaborazione di numerosi Partner esterni all'Ateneo (Città di Torino, Iren Servizi s.p.a, AIDI, AEIT, Elettrogruppo ZeroUNO), ha avuto il suo incipit con un concorso di idee da cui è stata selezionata l'dea vincitrice, approfondita in un secondo momento sino alla costruzione di un prototipo in scala reale
A 13-day, interferon-free regimen for chronic hepatitis C genotype 1 patients : between fear and hope
No full textHepatocellular carcinoma in chronic hepatitis C : from bench to bedside
No full textHepatocellular carcinoma (HCC) is the fifth most common cancer in men and seventh in women, accounting for 7 % of all cancers, and the third cause of cancer-related death worldwide. Nearly 90 to 95 % of all HCC occur in the context of known and often preventable risk factors, such as chronic viral hepatitis, alcohol abuse, and metabolic disorders. Although several experimental lines of research support a direct role for hepatitis C virus (HCV) in cancer promotion, cirrhosis is the main risk factor for this tumor, whereas other factors like alcohol and tobacco smoking are clearly able to accelerate HCC development. For this reason, cirrhotic patients with chronic HCV infection are subjected to abdominal ultrasound surveillance every 6 months, aimed at an early diagnosis of HCC to allow curative treatment options. Current strategies to positively impact on HCC incidence rates in HCV patients include prevention of cirrhosis development by avoiding metabolic, pharmacological, or social factors associated with accelerated progression of liver disease, or through virus eradication by interferon-based treatments. Moreover, a successful antiviral treatment has the added benefit of positively impacting on the rate of HCC development also in patients who are already cirrhotic
Genetic variation in interleukin-28B predicts hepatitis C treatment-induced viral clearance in genotype 1 patients : the dawn of a new era?
No full textA rapid point-of-care test for the diagnosis of HCV infection : tipping the balance to screening extension beyond high risk populations?
No full text
Selection of resistant-associated variants to the NS5A inhibitor daclatasvir : revenge of the hepatitis C virus
No full text- …
